News
By MATTHEW PERRONE, Associated Press. WASHINGTON (AP) — Shares of Sarepta Therapeutics plunged Monday after the biotech drugmaker reported a second death in connection with its gene therapy for ...
WASHINGTON (AP) — Shares of Sarepta Therapeutics plunged Monday after the biotech drugmaker reported a second death in connection with its gene therapy for muscular dystrophy.
Hosted on MSN22d
Sarepta Stock Plunges After Death of Second Patient Receiving Its Gene Therapy - MSNThe death of a second patient taking Sarepta Therapeutics’ controversial gene therapy for Duchenne muscular dystrophy is clouding the outlook for Sarepta, and for the gene therapy industry at ...
Shares of Sarepta Therapeutics have plunged again after the drugmaker reported a second death in connection with its gene therapy for muscular dystrophy. The biotech drugmaker said Sunday it was ...
WASHINGTON (AP) — Shares of Sarepta Therapeutics plunged Monday after the biotech drugmaker reported a second death in connection with its gene therapy for muscular dystrophy.
Shares of Sarepta Therapeutics plunged Monday after the biotech drugmaker reported a second death in connection with its gene therapy for muscular dystrophy. Sarepta reported the death over the ...
WASHINGTON – Shares of Sarepta Therapeutics plunged Monday after the biotech drugmaker reported a second death in connection with its gene therapy for muscular dystrophy.. Sarepta reported the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback